Online citations, reference lists, and bibliographies.
← Back to Search

Genomic Events Associated With Progression Of Pleural Malignant Mesothelioma

S. V. Ivanov, J. Miller, R. Lucito, C. Tang, A. Ivanova, J. Pei, M. Carbone, C. Cruz, Amanda M Beck, C. Webb, D. Nonaka, J. Testa, H. Pass
Published 2009 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Pleural malignant mesothelioma (MM) is an aggressive cancer with a very long latency and a very short median survival. Little is known about the genetic events that trigger MM and their relation to poor outcome. The goal of our study was to characterize major genomic gains and losses associated with MM origin and progression and assess their clinical significance. We performed Representative Oligonucleotide Microarray Analysis (ROMA) on DNA isolated from tumors of 22 patients who recurred at variable interval with the disease after surgery. The total number of copy number alterations (CNA) and frequent imbalances for patients with short time (<12 months from surgery) and long time to recurrence were recorded and mapped using the Analysis of Copy Errors algorithm. We report a profound increase in CNA in the short‐time recurrence group with most chromosomes affected, which can be explained by chromosomal instability associated with MM. Deletions in chromosomes 22q12.2, 19q13.32 and 17p13.1 appeared to be the most frequent events (55‐74%) shared between MM patients followed by deletions in 1p, 9p, 9q, 4p, 3p and gains in 5p, 18q, 8q and 17q (23‐55%). Deletions in 9p21.3 encompassing CDKN2A/ARF and CDKN2B were characterized as specific for the short‐term recurrence group. Analysis of the minimal common areas of frequent gains and losses identified candidate genes that may be involved in different stages of MM: OSM (22q12.2), FUS1 and PL6 (3p21.3), DNAJA1 (9p21.1) and CDH2 (18q11.2‐q12.3). Imbalances seen by ROMA were confirmed by Affymetrix genome analysis in a subset of samples. © 2008 Wiley‐Liss, Inc.
This paper references
10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
The Ki‐67 protein: From the known and the unknown
T. Scholzen (2000)
10.1002/ijc.23027
ADH‐1 suppresses N‐cadherin‐dependent pancreatic cancer progression
Y. Shintani (2008)
10.1158/0008-5472.CAN-06-3463
Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells.
W. Deng (2007)
Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
C. Lu (1993)
Preparation of slides and hybridization
R. Lucito (2003)
10.1016/S0046-8177(97)90171-4
Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues.
A. Han (1997)
10.3109/08977199009071502
Regulation of cell growth by recombinant oncostatin M.
D. Horn (1990)
10.1002/path.2252
Loss of PL6 protein expression in renal clear cell carcinomas and other VHL‐deficient tumours
A. Ivanova (2008)
10.1093/bioinformatics/bti611
Comparative analysis of algorithms for identifying amplifications and deletions in array CGH data
W. Lai (2005)
10.1158/0008-5472.CAN-06-0831
TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
Chao Jiang (2007)
10.1016/S0092-8674(00)81079-X
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
M. Serrano (1996)
Ncadherin distinguishes pleural mesotheliomas from lung adenocarcinomas: a ThinPrep immunocytochemical study
AC Han (1999)
10.1158/0008-5472.CAN-05-3907
Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.
Fernando López-Ríos (2006)
10.1038/ng1569
Array comparative genomic hybridization and its applications in cancer
D. Pinkel (2005)
Recent advances in the molecular analysis of human malignant mesothelioma.
A. De Rienzo (2000)
10.1038/sj.onc.1209842
Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13
S. Ivanov (2007)
10.1038/sj.onc.1201870
Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression
S. Frizelle (1998)
10.1158/0008-5472.CAN-06-1766
Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
N. Underhill-Day (2006)
10.1046/j.1471-4159.2001.00202.x
Complete inhibition of in vivo glioma growth by oncostatin M
M. Friedrich (2001)
Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma.
B. Balsara (1999)
National epidemiologic surveillance systems of asbestos-related disease and the exposed workers register.
A. Marinaccio (2006)
10.1016/J.EXER.2006.06.014
Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, α-catenin and β-catenin in retinoblastoma
Adithi Mohan (2007)
10.1158/1078-0432.CCR-0578-03
N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
S. Nakajima (2004)
10.1016/0165-4608(95)00358-4
Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization.
P. Kivipensas (1996)
10.1038/sj.onc.1206158
Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells
F. Zhang (2003)
10.1517/14796694.1.1.79
3p21.3 tumor suppressor cluster: prospects for translational applications.
L. Ji (2005)
10.1016/0046-8177(95)90302-X
The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas.
A. Peralta Soler (1995)
Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo.
L. Ji (2002)
10.1038/sj.onc.1205381
Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells
S. Toyooka (2002)
10.1007/BF02306613
Surgically debulked malignant pleural mesothelioma: Results and prognostic factors
H. Pass (2006)
10.3892/OR.15.5.1181
Expression profile of N-cadherin differs from other classical cadherins as a prognostic marker in renal cell carcinoma.
T. Shimazui (2006)
10.1159/000077515
Comparative genomic hybridization (CGH): ten years of substantial progress in human solid tumor molecular cytogenetics
E. Gebhart (2004)
10.1007/s10577-005-2168-x
Array CGH technologies and their applications to cancer genomes
J. Davies (2005)
10.1101/GR.138300
Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations.
R. Lucito (2000)
10.1091/MBC.E05-03-0186
Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway.
J. Qi (2005)
Expression of motility
A Mohan
Preparation of target DNA
R. Lucito (2003)
10.1093/JNCI/DJJ229
A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
Meng-Feng Tsai (2006)
10.1038/sj.onc.1210270
Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer
H. Wikman (2007)
10.1093/bioinformatics/bti113
CGH-Explorer: a program for analysis of array-CGH data
O. C. Lingjærde (2005)
10.1038/sj.onc.1210547
Evaluation of the 3p21.3 tumour-suppressor gene cluster
L. Hesson (2007)
10.1002/path.2146
Autoimmunity, spontaneous tumourigenesis, and IL‐15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1
A. Ivanova (2007)
10.1016/S0166-4328(01)00297-2
Controlling the false discovery rate in behavior genetics research
Y. Benjamini (2001)
10.1101/GR.1349003
Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation.
R. Lucito (2003)
10.1002/(SICI)1097-0142(19990425)87:2<83::AID-CNCR7>3.0.CO;2-S
N‐cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas
Aaron C. Han (1999)
10.1016/J.MOLCEL.2007.08.008
RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein.
D. Matallanas (2007)
10.1158/0008-5472.CAN-07-1348
A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis.
E. Pérez-Gómez (2007)
Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
A. Mohan (2007)
10.1093/CARCIN/15.11.2673
Expression of cell adhesion molecules and connexins in gap junctional intercellular communication deficient human mesothelioma tumour cell lines and communication competent primary mesothelial cells.
K. Pelin (1994)
10.1007/0-387-28274-2_6
Cytogenetics of Malignant Mesothelioma
Sinoula Apostolou (2005)
10.1038/nature06084
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a
P. Krimpenfort (2007)
The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
M. Lerman (2000)
p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.
J. Cheng (1994)
10.1093/JNCI/95.8.598
Using gene expression ratios to predict outcome among patients with mesothelioma.
G. Gordon (2003)
10.1158/0008-5472.CAN-05-3589
Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Z. Liu (2006)



This paper is referenced by
10.1016/j.canlet.2012.02.034
Immunity and malignant mesothelioma: from mesothelial cell damage to tumor development and immune response-based therapies.
V. Izzi (2012)
10.1016/j.cancergen.2013.04.006
Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines.
Geula Klorin (2013)
10.3390/jdb7020007
Mesothelium and Malignant Mesothelioma
Emilye Hiriart (2019)
Molecular and Cellular Pathobiology Cancer Research hsa-miR-29 c * Is Linked to the Prognosis of Malignant Pleural Mesothelioma
H. Pass (2010)
10.1155/2015/902419
Combined Analysis of SNP Array Data Identifies Novel CNV Candidates and Pathways in Ependymoma and Mesothelioma
G. Wajnberg (2015)
10.1186/s12885-019-5652-y
CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
E. Kettunen (2019)
10.1158/1078-0432.CCR-11-0962
Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy
C. Kemp (2011)
10.18632/oncotarget.22817
Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma
Marieke Hylebos (2017)
10.1371/journal.pone.0025391
LRRN4 and UPK3B Are Markers of Primary Mesothelial Cells
M. Kanamori-Katayama (2011)
10.1158/0008-5472.CAN-10-2164
LATS2 is a tumor suppressor gene of malignant mesothelioma.
H. Murakami (2011)
Treated with Pemetrexed / Carboplatin PatientsGroup-1 as Predictors of Responsiveness in Mesothelioma Thymidylate Synthase and Excision Repair Cross-Complementing
Paolo Andrea Zucali (2011)
10.1007/978-3-030-30766-0_11
Lung Cancer: Molecular Markers of Occupational Carcinogens
P. Nymark (2020)
10.1136/jclinpath-2011-200208
Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues
M. Takeda (2011)
10.1186/s12885-017-3382-6
Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma
Sophie Sneddon (2017)
10.1111/j.1349-7006.2009.01336.x
Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells
Y. Sekido (2010)
Molecular profiling of malignant pleural mesothelioma and pulmonary fibrosis
P. Lindholm (2009)
10.1158/1078-0432.CCR-10-2873
Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin
P. A. Zucali (2011)
10.1158/0008-5472.CAN-09-3993
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.
H. Pass (2010)
10.1016/j.jtho.2016.05.020
The Genetic Landscape of Malignant Pleural Mesothelioma: Results from Massively Parallel Sequencing
Marieke Hylebos (2016)
omic Profiling Reveals Alternative Genetic Pathways of ingioma Malignant Progression Dependent R he Underlying NF 2 Status
Stéph Jonat Rona (2010)
Molecular Alterations in Asbestos-Related Lung Cancer
P. Nymark (2010)
10.1158/1078-0432.CCR-20-1306
Ganetespib in Combination with Pemetrexed–Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial
D. Fennell (2020)
10.1016/j.rmed.2015.05.014
Pleural neoplastic pathology.
G. Karpathiou (2015)
10.1007/978-1-4471-2825-0_12
Lung Cancer: Molecular Markers
P. Nymark (2014)
10.3892/ijo.2011.1158
Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells.
Yoshie Yoshikawa (2011)
10.18632/ONCOTARGET.4537
Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunity
R. Uzhachenko (2015)
10.1080/10937404.2011.556051
Role of Mutagenicity in Asbestos Fiber-Induced Carcinogenicity and Other Diseases
Sarah X. L. Huang (2011)
Identification of BAP1 as a predisposing gene for malignant mesothelioma
Masaki Nasu (2012)
10.1016/j.ajpath.2010.10.039
Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma.
D. Jean (2011)
Molecular changes of malignant mesothelioma in the testis and their impact on prognosis: Analyses of two cases
G. Serio (2016)
10.5858/arpa.2011-0215-RA
Molecular changes in mesothelioma with an impact on prognosis and treatment.
D. Jean (2012)
10.12691/AJMBR-1-4-8
Comparative Genomic Hybridization Studies on Mesothelioma Show a Parallel Fate of 1p21-1p22 and 9p21 Bands and a Chromosomally Stable Sub-Group
M. Ombretta (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar